FAK-PD1 - Aphase I/II Study to Assess Safety, Tolerability and Preliminary Activity of the Combination of FAK and PD-1 Inhibitioin in Patients with Advanced Solid Malignancies....

Project Details

StatusFinished
Effective start/end date1/01/16 → 31/10/23

Funding

  • Other: £16,178.00